STOCK TITAN
  1. Home
  2. CTRVP

HEPION PHARM PFD (CTRVP) Stock Price, News & Analysis

CTRVP OTC
Published by Stock Titan Data refreshed

What Changed

Company Description

HEPION PHARM PFD (OTC: CTRVP) is classified in the biotechnology industry within the Healthcare sector.

For FY2025, HEPION PHARM PFD reported net income of -$8.3M and diluted earnings per share of -$0.88.

This page collects what Stock Titan holds for CTRVP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

CTRVP Metrics & Rankings

Piotroski F-Score
2/9
#6,171

Latest News

View All

No recent news available for CTRVP.

SEC Filings

View All

[3] Ten percent owner discloses stake in Hepion (HEPA)

[SCHEDULE 13D/A] A new 10% backer steps into Hepion (HEPA); the terms stand out

[SCHEDULE 13G] One investor now holds 5.7% of Hepion (HEPA)

[4] Insider buys 12.5M warrants in Hepion Pharmaceuticals (HEPA) that need shareholder approval

[DEF 14C] Insiders holding 51% of Hepion (HEPA) back reverse split and 750M-share increase

HEPION PHARM PFD has filed 5 recent SEC filings, including 1 Form 3, 1 Form 4, 1 Form SCHEDULE 13D/A, 1 Form SCHEDULE 13G. The most recent filing was submitted on September 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CTRVP SEC filings →

Financial Highlights

View Full Financials

operating income reached -$4.2M, and net income was -$8.3M. Diluted earnings per share stood at -$0.88. The company generated -$3.3M in operating cash flow. With a current ratio of 10.25, the balance sheet reflects a strong liquidity position.

-$8.3M
Net Income (FY2025)
-$0.88
Diluted EPS (FY2025)
-$3.3M
Operating Cash Flow
10.25
Current Ratio
-$4.2M
Operating Income
—
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CTRVP Company Profile & Sector Positioning

HEPION PHARM PFD (CTRVP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Frequently Asked Questions

What is the net income of HEPION PHARM PFD (CTRVP)?

The FY2025 net income of HEPION PHARM PFD (CTRVP) is -$8.3M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of HEPION PHARM PFD (CTRVP)?

The diluted earnings per share (EPS) of HEPION PHARM PFD (CTRVP) is -$0.88 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of HEPION PHARM PFD (CTRVP)?

The operating cash flow of HEPION PHARM PFD (CTRVP) is -$3.3M. Learn about cash flow.

What is the current ratio of HEPION PHARM PFD (CTRVP)?

The current ratio of HEPION PHARM PFD (CTRVP) is 10.25, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of HEPION PHARM PFD (CTRVP)?

The operating income of HEPION PHARM PFD (CTRVP) is -$4.2M. Learn about operating income.